Social, cultural and ethical aspects of drug use-changes over 40 years: A personal look back

European Journal of Clinical Pharmacology

Volumn 64, Issue 2, 2008, Pages 107-114

  Herxheimer, Andrew ^a   Sanz, Emilio ^b  

^a UK COCHRANE CENTRE   (United Kingdom)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; CLINICAL PHARMACY; CULTURAL ANTHROPOLOGY; DRUG INDUSTRY; DRUG LEGISLATION; DRUG USE; ETHICS; GOVERNMENT REGULATION; LAW SUIT; PHARMACIST; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SOCIAL ASPECT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; CULTURAL CHARACTERISTICS; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOLOGY, CLINICAL; SOCIAL VALUES;

EID: 39149106127     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-007-0429-7     Document Type: Review

References (29)

1. Talalay P (ed) (1964) Drugs in our society. Johns Hopkins Press, Baltimore
2. Proger S (ed) (1968) The medicated society. Collier-Macmillan, Toronto
3. Bush P, Trakas D, Sanz E et al (eds) (1996) Children, medicines and culture. Haworth, Binghampton, NY
4. Trakas D, Sanz E (eds) (1996) Childhood and medicine use in cross-cultural perspective: a European concerted action. DG XII Euro-Report EUR 16646EN. European Commission, Luxembourg
5. Sanz E (1999) Pharmacological treatment for asthma: disease, diagnosis, drugs and patients. Int J Risk Saf Med 12:157-162
6. NHSS (2004) National healthyschool standarddrug education (including alcohol and tobacco). http://www.wiredforhealth.gov.uk/PDF/ nhss_drug_education_2004.pdf. Accessed 7 Oct 2007
7. Medawar C, Herxheimer A, Bell A, Jofre S (2002) Paroxetine, PANORAMA and user reporting of ADRs: consumer intelligence matters in clinical practice and post-marketing drug surveillance. Int J Risk Saf Med 15(4):161-169
8. Medawar C, Herxheimer A (2003/2004) A comparison of adverse drug reaction reports from professionals and users, relating to risk of dependence and suicidal behaviour with paroxetine. Int J Risk Saf Med 16:3-17
9. Golomb BA, McGraw JJ, Evans MA, Dimsdale JE (2007) Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance. Drug Saf 30:669-675
10. International Society of Drug Bulletins (2007) http://www.isdbweb.org. Accessed 7 Oct 2007
11. ISDB (2001) Declaration on therapeutic advance in the use of medicines. http://www.isdbweb/pag/documents/ISDB-decl-english.pdf. Accessed 14 Nov 2007
12. Chalmers I, Altman DG (eds) (1995) Systematic reviews. BMJ, London
13. Egger M, Davey Smith G, Altman DG (eds) (2001) Systematic reviews in health care: meta-analysis in context, 2nd edn. BMJ, London
14. The Cochrane Library (2007) http://thecochranelibrary.com. Accessed 7 Oct 2007
15. Loke YK, Price D, Herxheimer A (2007) For the Cochrane adverse effects methods group. Systematic reviews of adverse effects: framework for a structured approach. BMC Med Res Methodol 7:32
16. Waller PC, Wood SM, Langman MJS, Breckenridge AM, Rawlins MD (1992) Review of company postmarketing surveillance studies. BMJ 304:14142-14770
17. Nieto A, Mazon A, Pamies R et al (2007) Adverse effects of inhaled corticosteroids in funded and nonfunded studies. Arch Intern Med 167:2047-2053
18. Health Technology Assessment (2007) NIHR Health Technology Assessment Programme. http://www.hta.nhsweb.nhs.uk/. Accessed 11 Nov 2007
19. National Institute for Health and Clinical Excellence (2007) http://www.nice.org.uk. Accessed 10 Nov 2007
20. INAHTA (2007) http://www.inahta.org. Accessed 10 Nov 2007
21. Guidelines International Network (2007) http://www.g-i-n.net. Accessed 11 Nov 2007
22. Mayor S (2006) Severe adverse reactions prompt call for trial design changes. BMJ 332:683
23. Rosenthal E (2006) Ill-fated U.K. drug trial bares testing loopholes. Herald Tribune, New York. http://www.iht.com/articles/2006/07/30/news/pharma. php. Accessed 10 Nov 2007
24. Laurence DR (2006) Research ethics committees and the law: indemnity and independence. Res Ethics Rev 2:140-143
25. Meador CK (1994) The last well person. N Engl J Med 330(6):440-441
26. Herxheimer A, Ziebland S (2004) The DIPEx project: collecting personal experiences of illness and health care. In: Hurwitz B, Greenhalgh T, Skultans V (eds) Narrative research in health and illness. BMJ Books, Blackwell
27. Shirkey HJ (1968) Pediatrics. 72(1):119-120
28. Bohaychuck W, Ball G (2004) Conducting GCP complaint clinical research. Some of their findings are summarised in: Medawar C, Hardon A (eds) Medicines out of control? Aksant, Amsterdam, pp 166-169
29. Illich I (1975) Medical nemesis: the expropriation of health. Marion Boyars, London